- 01The patch is a skin problem; the blood test answers the health question
Removing xanthelasma changes how the eyelid looks and nothing about the cholesterol or heart risk behind it. About half of people with xanthelasma have abnormal lipids 3, and in the largest study it went with a 48% higher heart-attack risk even after allowing for cholesterol 1, so the lipid panel, ApoB and Lp(a) set the plan.
Xanthelasma is a soft, butter-yellow patch of cholesterol-filled cells in the eyelid skin, usually near the nose. It does not hurt, itch or affect vision, but about half of the adults who have it have abnormal blood lipids 3, and the cells inside it are the same cholesterol-packed cells that build plaque in arteries. That is why a dermatologist who spots xanthelasma usually asks about your cholesterol before talking about removal.
What xanthelasma is and what it looks like
The name comes from Greek: xanthos means yellow and elasma means plate, and palpebrarum means of the eyelids. Xanthelasma shows up as soft, flat or slightly raised yellow to orange plaques, often on both sides in a mirror pattern. The upper lid near the inner corner is the usual first spot, then the lower lid, and in some people all four lids. The patches are painless, do not itch and grow slowly over months to years 3.
Under a microscope, xanthelasma is a cluster of foam cells (immune cells called macrophages that have swallowed so much cholesterol they look bubbly) sitting in the dermis just under the skin surface 3. Foam cells are also the first building block of plaque inside artery walls, which is the reason doctors link the eyelid and the heart. In the Copenhagen City Heart Study, 563 of 12,745 adults (4.4%) had xanthelasma at the start 1. Xanthelasma is more common in women and usually appears between the 40s and 60s 3. A related eye sign, arcus (a gray-white ring at the edge of the cornea), is common with age; before 45 it is a stronger clue to inherited high cholesterol 5.
What causes xanthelasma? Cholesterol deposits around the eyes form when foam cells collect in the lid skin. The usual drivers are high LDL or an inherited lipid disorder, an underactive thyroid, diabetes, a bile-duct liver disease, kidneys leaking protein and some medicines 3. In about half of people the lipid panel comes back normal 3, and the cause stays unclear.
Yellow bumps around the eyes: is it xanthelasma or something else?
Several eyelid bumps can pass for xanthelasma. Three of them must not be missed: basal cell carcinoma (a common skin cancer), sebaceous carcinoma (a cancer of the eyelid oil glands) and necrobiotic xanthogranuloma (a rare skin disease tied to abnormal blood proteins). Color, feel and speed sort most of the rest. A dermatologist or eye doctor can usually tell by looking; a small biopsy settles any doubt.
| Bump | Color and feel | Where | Pain | How fast | What to do |
|---|---|---|---|---|---|
| Xanthelasma | Soft, flat, yellow to orange plaque | Inner upper and lower lids, often both sides | None | Months to years | Lipid panel; removal is optional |
| Milia | Tiny, hard, pearly white dots | Lids and cheeks | None | Weeks | Usually harmless; a clinician can confirm and extract them |
| Syringoma | Small skin-colored or slightly yellow bumps, firm | Lower lids, in clusters | None | Slow | Usually harmless sweat-duct growths; a clinician can confirm |
| Sebaceous hyperplasia | Yellowish bump with a central dip | Forehead, cheeks, sometimes lids | None | Slow | Usually harmless oil-gland growth; a clinician can confirm |
| Chalazion | Firm, round lump in the lid | Lid edge or within the lid | Mild or none | Days to weeks | Warm compresses; see a doctor if it lasts beyond a few weeks or keeps coming back in the same spot, which needs a biopsy |
| Stye | Red, tender bump with a head | Lid margin at a lash | Yes | 1 to 3 days | Warm compresses; usually clears in a week |
| Basal cell carcinoma | Pearly or waxy, may bleed or crust, does not heal | Often the lower lid, usually one side | Usually none | Slow but steady | See a doctor; needs a biopsy |
| Sebaceous carcinoma | Firm yellowish nodule or thickened lid; can look like a chalazion that keeps coming back | Usually the upper lid, one side | Usually none | Weeks to months | See a doctor; needs a biopsy |
| Necrobiotic xanthogranuloma | Firmer, red-orange to yellow plaque that can ulcerate | Around the eyes, often spreading | Sometimes | Grows over months | See a doctor; needs a biopsy and blood tests for a paraprotein (an abnormal antibody) |
Does xanthelasma mean high cholesterol?
Xanthelasma means high cholesterol in about half of the adults who have it 3; in one Taiwanese series, 25 of 50 patients with lipid results had dyslipidemia 9. A 2020 review of 15 case-control studies, covering 854 people with xanthelasma, found they had higher total cholesterol, LDL cholesterol and apolipoprotein B (ApoB, the protein that marks each artery-clogging particle), somewhat lower apolipoprotein A1 (the main protein on HDL, the protective particle) and thicker carotid artery walls than people without it 2.
A normal LDL cholesterol does not close the question. Two blood tests can still be high when LDL looks fine. ApoB counts the particles that carry cholesterol into artery walls, and it can run high when triglycerides are high or insulin resistance (cells responding poorly to insulin) is present. Lipoprotein(a), or Lp(a), is an inherited particle that a standard panel never measures; the 2019 European dyslipidemia guidelines advise considering a measurement at least once in every adult's life 6. The lipid panel guide walks through each line of the standard report.
ApoB counts the plaque-forming particles, one ApoB per particle. LDL cholesterol weighs the cholesterol inside LDL particles. Same particles, different measurement.
Do your apoB and LDL agree?
Enter both numbers to see whether your particle count and your cholesterol tell the same story. Nothing leaves your browser.

Xanthelasma and heart risk: the Copenhagen numbers
The best evidence comes from the Copenhagen City Heart Study, which followed 12,745 Danish adults for up to 33 years 1. The researchers adjusted for cholesterol, triglycerides, smoking, blood pressure, weight and other known risk factors, so the extra risk below sits on top of what a lipid panel already shows.
| Outcome | Risk with xanthelasma vs without | Plain reading |
|---|---|---|
| Heart attack | 1.48 times (hazard ratio) | About 48% higher |
| Ischemic heart disease (narrowed heart arteries) | 1.39 times | About 39% higher |
| Severe atherosclerosis | 1.69 times (odds ratio) | About 69% higher odds |
| Death from any cause | 1.14 times | About 14% higher |
| Ischemic stroke | 0.94 times | No increase |
In the Copenhagen data, 14% is the extra risk of death from any cause; severe atherosclerosis carried 69% higher odds 1. Absolute numbers matter more than ratios for one person. Among men aged 70 to 79, the 10-year risk of ischemic heart disease was 53% with xanthelasma and 41% without; among women of the same age it was 35% and 27% 1. At younger ages the starting risk is far lower, so the absolute gap is smaller too, and your own lipid, ApoB, Lp(a) and blood pressure results say more than the ratio. Arcus alone added little once the other factors were counted 1.
Xanthelasmata predict risk of myocardial infarction, ischaemic heart disease, severe atherosclerosis, and death in the general population, independent of well known cardiovascular risk factors, including plasma cholesterol and triglyceride concentrations.Christoffersen M et al., BMJ 2011 1
A 2026 review in the Journal of Clinical Lipidology read the Copenhagen result more cautiously and concluded that xanthelasma and arcus may support a cardiovascular evaluation but are not independent risk markers 4. We take a middle position. Xanthelasma is a good reason to check lipids, ApoB, Lp(a), blood pressure and smoking status, and the results of those checks set the plan. A heart-risk review may also include a coronary calcium score when lipids look normal and risk is still uncertain. These figures describe long-term risk; chest pain, pressure or breathlessness is a different matter and needs a call to 911.
The blood tests usually checked with xanthelasma
Xanthelasma blood tests answer two questions: are blood lipids high, and is something else raising them? The table lists each test, why it is checked and the result that changes the plan. A risk enhancer is a result that US guidelines say tips the balance toward cholesterol treatment when overall heart risk is borderline 7.
| Test | Why it is checked | The result that changes the plan |
|---|---|---|
| Lipid panel: total cholesterol, LDL, HDL, triglycerides, non-HDL | The core check behind xanthelasma 3 | LDL 190 mg/dL or more points to possible familial hypercholesterolemia 7; any high LDL or non-HDL means a risk review |
| ApoB | Counts the plaque-forming particles, which can be high even when LDL looks normal 2 | 130 mg/dL or more is a risk enhancer in the 2018 AHA/ACC guideline 7 |
| Lp(a) | Inherited particle; European guidelines advise considering one measurement in adult life 6 | 50 mg/dL or 125 nmol/L or more is a risk enhancer in the 2018 AHA/ACC guideline 7 |
| TSH | An underactive thyroid raises LDL | High TSH: a clinician usually treats the thyroid first, then rechecks lipids |
| HbA1c or fasting glucose | Type 2 diabetes raises triglycerides and lowers HDL | A1C 6.5% or more suggests diabetes; 5.7 to 6.4% is prediabetes |
| Liver panel with ALP | Xanthelasma is a classic sign of primary biliary cholangitis, an autoimmune bile-duct disease 3 | High ALP: a clinician usually orders an antimitochondrial antibody (AMA) test next (autoimmune antibodies explained) |
| Urine protein/creatinine ratio | Nephrotic syndrome (kidneys leaking protein) drives cholesterol up | Heavy protein loss needs a kidney work-up |
Read your Lp(a), in the right unit
mg/dL and nmol/L are not the same scale. Enter your value with its unit. Nothing leaves your browser.

CalculatorLDL calculatorWork out LDL from your total cholesterol, HDL and triglycerides if your report leaves it out.Work it out Markers to read beside xanthelasma

Most people do not need to fast for a lipid panel 7; a clinician may ask you to fast if triglycerides were high before (fasting before a blood test). A medication review belongs in the same visit, because oral retinoids, corticosteroids, estrogen and some HIV and immune drugs can raise lipids.
A liver panel lists ALP beside other enzymes; the liver enzymes guide explains which pattern points to the bile ducts. If every result is normal, clinicians usually keep an eye on blood pressure, smoking and weight and recheck lipids on the usual schedule; xanthelasma alone is not usually a reason for testing every few months.
When xanthelasma points to familial hypercholesterolemia
Familial hypercholesterolemia (FH) is an inherited condition that keeps LDL high from birth. Xanthelasma itself scores no points in the Dutch Lipid Clinic Network score that clinicians use to rate the chance of FH, while tendon xanthomas score 6 points and arcus before 45 scores 4 5. Even so, xanthelasma in a younger adult is a reason to look harder, and in a child it should always lead to a lipid check 3.
Example: an adult LDL against the FH linemg/dL
CalculatorCholesterol converterConvert a result in mmol/L to mg/dL to compare it with the 190 mg/dL line.Work it out Treating the cause: cholesterol and heart risk
When lipids or ApoB come back high, the plan for someone with xanthelasma follows the same steps as for high cholesterol in general. That means more soluble fiber and less saturated fat (foods that lower cholesterol), regular activity, weight loss where it applies, no smoking, a DASH-style diet if blood pressure is also high, and medication when a clinician judges overall risk calls for it. A statin such as atorvastatin is usually the first medicine, and other drugs are added for higher risk or FH; the cholesterol medications guide compares them. Any secondary cause found on the tests (thyroid, diabetes, liver or kidney) is treated in its own right, and metabolic syndrome often sits behind high triglycerides with low HDL (cholesterol vs triglycerides).
Prescription medicines a clinician may use for the cholesterol behind xanthelasma
Lowering high lipids may help stop new xanthelasma patches forming 3, and a few case reports describe small, recent patches shrinking. Larger, older patches rarely disappear, and no trial has used xanthelasma size as its end point. Cholesterol treatment is for heart risk, decided with a clinician; clearing an existing patch usually takes removal. After a statin is started or changed, clinicians usually repeat the lipid panel in 4 to 12 weeks, then every 3 to 12 months as needed 7.
Xanthelasma removal options compared
Most people remove xanthelasma for appearance, since the patches rarely cause symptoms. Removal is done by a dermatologist, an oculoplastic surgeon (an eyelid specialist) or a plastic surgeon, using excision, laser, trichloroacetic acid, radiofrequency or freezing 3. Insurers usually count it as cosmetic and often do not cover it. Getting lipids checked before removal makes sense, because the cause stays after the patch goes 9.
| Method | Best for | Sessions | Main risks | Darker skin note |
|---|---|---|---|---|
| Surgical excision | Larger or deeper plaques | Usually one | Scar in the lid crease; removing too much skin can pull the lower lid down | Scar may darken |
| Trichloroacetic acid (TCA), applied by a clinician | Small, flat plaques | Often more than one | Redness, scarring if too strong | Higher risk of dark or light patches |
| Ablative laser (CO2 or erbium:YAG, lasers that vaporize thin skin layers) | Flat to moderate plaques | Often more than one | Redness, scarring, pigment change | Pigment change is more common |
| Radiofrequency | Small plaques | Often more than one | Scarring, pigment change | Pigment change possible |
| Cryotherapy (freezing) | Small plaques | Often more than one | Swelling, blistering | Can leave lasting pale spots |
Xanthelasma comes back often after any method 3. In a 1976 follow-up of surgical excision, one operation was definitive in more than half of the people treated for the first time, and recurrence was expected when all four lids were involved, when an underlying lipid disorder was present, or after more than one earlier recurrence 8. A 2018 Taiwanese series of 113 patients found recurrence in 17.5%, with no statistically significant difference between methods 9.
When to see a doctor about xanthelasma
- Book a routine visit and ask about a lipid panel when you first notice xanthelasma, at any age.
- Go sooner if you are under 40, have a family history of early heart disease, or notice lumps on your tendons.
- Be seen promptly if an eyelid bump bleeds, ulcerates, grows quickly, feels firm, sits on one side only and keeps changing, or keeps coming back in the same spot.
- Be seen promptly if xanthelasma comes with itching all over, deep tiredness or yellowing of the skin or eyes, which can point to a liver cause.
- Call 911 for chest pain, pressure or breathlessness, especially with sweating or nausea; get a same-day visit if chest discomfort or breathlessness comes on with exertion and settles with rest.
If FH is suspected or confirmed, guidelines advise lipid checks for parents, siblings and children 5; a clinician or lipid clinic can arrange this. The heart health hub gathers the tests and guides for the rest of the heart-risk picture.
See a dermatologist or eye doctor promptly for an eyelid bump that bleeds, ulcerates, grows fast, feels firm, is one-sided and changing, or looks like a stye or chalazion that keeps coming back in the same spot, as it needs a biopsy. Call 911 for chest pain, pressure or breathlessness. Never use acids, garlic or removal pens on eyelid skin, and never start, stop or change a cholesterol medicine without your prescriber.
Citations
- Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjaerg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ 2011;343:d5497
- Chang HC, Sung CW, Lin MH. Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: a systematic review and meta-analysis. J Am Acad Dermatol 2020;82(3):596-605
- Blair K, Shah SS. Xanthelasma Palpebrarum. StatPearls, StatPearls Publishing (updated 2026)
- Varghese RT. Ocular manifestations of lipid disorders: clinical clues for lipidologists. J Clin Lipidol 2026
- Nordestgaard BG et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Consensus Statement of the European Atherosclerosis Society. Eur Heart J 2013;34:3478-3490
- Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41:111-188
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation 2019;139(25):e1082-e1143
- Mendelson BC, Masson JK. Xanthelasma: follow-up on results after surgical excision. Plast Reconstr Surg 1976;58(5):535-538
- Wang KY, Hsu KC, Liu WC, Yang KC, Chen LW. Relationship Between Xanthelasma Palpebrarum and Hyperlipidemia. Ann Plast Surg 2018;80(2S Suppl 1):S84-S86
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel (Adult Treatment Panel III). JAMA 2001;285(19):2486-2497
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.




